We show that tumor cells have an increased expression of several markers (CD47, IL7R, NKG7, CD80, CD84, CSF1R, NLRC5/CITA, CD2 and IRF3) that may be involved in regulating the level of immune infiltration and the effect on tumor immunity. The gene discussed is IRF3; the disease is neoplasm.